69 related articles for article (PubMed ID: 2416652)
1. Platelet function in hyperlipoproteinaemia.
Parízek M; Parízková M; Kubisz P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):752-9. PubMed ID: 2416652
[TBL] [Abstract][Full Text] [Related]
2. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.
Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574
[TBL] [Abstract][Full Text] [Related]
3. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
Micheli H; Pometta D; Gustafson A
Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343
[TBL] [Abstract][Full Text] [Related]
4. [Platelet aggregation in hyperlipoproteinemias].
Calabrese S; Da Col PG; Giansante C; Morgante O; Cattin L
Minerva Med; 1982 May; 73(22):1541-6. PubMed ID: 7088380
[TBL] [Abstract][Full Text] [Related]
5. [Behavior of HDL cholesterol and the apoproteins A1 A2 and B in the central circulation in patients with coronary disease and genetically determined hyperlipoproteinemias].
Wichmann T; Grafnetter D; Meyer E; Teichmann W; Schmerling S
Wien Klin Wochenschr; 1985 Jul; 97(14):606-9. PubMed ID: 4049883
[TBL] [Abstract][Full Text] [Related]
6. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
[TBL] [Abstract][Full Text] [Related]
7. Non-HDL cholesterol and apoB in dyslipidaemia.
Sniderman AD; Hogue JC; Bergeron J; Gagné C; Couture P
Clin Sci (Lond); 2008 Jan; 114(2):149-55. PubMed ID: 17868037
[TBL] [Abstract][Full Text] [Related]
8. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
Ferlito S; Ricceri M; Ossino AM
Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
[TBL] [Abstract][Full Text] [Related]
9. Blood plasma apolipoproteins A-I and B in different types of hyperlipoproteinaemia: comparative analysis of population groups in Moscow and Prague.
Metel'skaya VA; Ceska R; Perova NV; Sobra J
Cor Vasa; 1988; 30(3):168-76. PubMed ID: 3139364
[TBL] [Abstract][Full Text] [Related]
10. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
[TBL] [Abstract][Full Text] [Related]
11. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
Ravindran R; Krishnan LK
Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
[TBL] [Abstract][Full Text] [Related]
12. Platelet function studies in myeloproliferative disorders.
Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral elastase on lipid metabolism, platelet function, and blood coagulability in patients with diabetes mellitus.
Furui H; Yamada Y; Yamauchi K; Hayashi H; Saito H; Sotobata I
Clin Ther; 1989; 11(6):786-94. PubMed ID: 2532960
[TBL] [Abstract][Full Text] [Related]
14. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
15. Platelet reactivity: a contribution to age dependence studies.
Parízek M; Kubisz P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):621-7. PubMed ID: 2465242
[TBL] [Abstract][Full Text] [Related]
16. The effect of simvastatin on HDL cholesterol in hyperlipidemic patients. Evidence of a relationship with the changes in serum triglyceride level.
Branchi A; Rovellini A; Fiorenza AM; Maraffi F; Gandini R; Sommariva D
Int J Clin Pharmacol Ther; 1996 Sep; 34(9):384-9. PubMed ID: 8880287
[TBL] [Abstract][Full Text] [Related]
17. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
Goubran F; Maklady F; Saad M; el-Ashry M
Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
19. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias].
Apostolov I; Naumova R; Balabanski L; Goranov I
Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586
[TBL] [Abstract][Full Text] [Related]
20. Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability.
Szczeklik A; Gryglewski RJ; Domagala B; Dworski R; Basista M
Thromb Haemost; 1985 Aug; 54(2):425-30. PubMed ID: 3909500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
